Back to AVBP
GOLDMAN SACHS GROUP INC → AVBP
GOLDMAN SACHS GROUP INC AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
14
Latest value
$292K
Q2 2026
Peak value
$18.4M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $7.1M |
| Q2 2025 | $261K |
| Q3 2025 | $7.8M |
| Q3 2025 | $215K |
| Q4 2025 | $1.2M |
| Q4 2025 | $13.7M |
| Q4 2025 | $13.7M |
| Q4 2025 | $1.2M |
| Q1 2026 | $12.1M |
| Q1 2026 | $7.4M |
| Q1 2026 | $211K |
| Q2 2026 | $18.4M |
| Q2 2026 | $11M |
| Q2 2026 | $292K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $292K | 8.4K | — | — |
| Q2 2026 | $11M | 315.3K | — | — |
| Q2 2026 | $18.4M | 530.1K | — | — |
| Q1 2026 | $211K | 9.1K | — | — |
| Q1 2026 | $7.4M | 319.2K | — | — |
| Q1 2026 | $12.1M | 525.0K | — | — |
| Q4 2025 | $1.2M | 60.7K | — | — |
| Q4 2025 | $13.7M | 681.9K | — | — |
| Q4 2025 | $13.7M | 681.9K | — | — |
| Q4 2025 | $1.2M | 60.7K | — | — |
| Q3 2025 | $215K | 11.7K | — | — |
| Q3 2025 | $7.8M | 420.3K | — | — |
| Q2 2025 | $261K | 12.0K | — | — |
| Q2 2025 | $7.1M | 327.2K | — | — |
Other funds holding AVBP
$80.9M
$70M
$65.5M
$59.2M
$58.8M
$58.8M
$56M
$54.7M